AIQUIRE INC. – Trademark Portfolio
Entity Type: 03
AIQUIRE INC. holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 12 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 6 trademarks are registered and 8 are pending. Notable registered marks include PIXIS, OPPGEN, P PIXIS, OPPGENETIX, and SOCIAL HUSTLE. The owner is based in CHICAGO, IL.
625 W. ADAMS ST.
CHICAGO, IL 60661
Showing of trademarks Trademarks
Trademark Classifications
AIQUIRE INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does AIQUIRE INC. have?
AIQUIRE INC. has 16 U.S. trademarks filed with the USPTO. Of these, 6 registered, 8 pending, 2 abandoned.
What trademark classes does AIQUIRE INC. file in?
AIQUIRE INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are AIQUIRE INC.'s most well-known trademarks?
AIQUIRE INC.'s registered trademark portfolio includes well-known marks such as PIXIS, OPPGEN, P PIXIS, OPPGENETIX, and SOCIAL HUSTLE. These are among 6 currently registered trademarks in the portfolio.
What is AIQUIRE INC.'s trademark registration success rate?
AIQUIRE INC. has a 75% trademark registration rate, with 6 out of 8 resolved applications resulting in successful registration. Currently, 8 applications are pending review.